These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 15529628)

  • 1. Continuous glucose monitoring: physiologic and pathophysiologic significance.
    Ionescu-Tîrgovişte C; Guja C; Ioacără S; Dumitrescu D; Tomescu I
    Rom J Intern Med; 2004; 42(2):381-93. PubMed ID: 15529628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
    Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan.
    Bakiner O; Ertorer ME; Bozkirli E; Tutuncu NB; Demirag NG
    Acta Diabetol; 2009 Mar; 46(1):63-5. PubMed ID: 18825302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Achieving glycemic control: cornerstone in the treatment of patients with multiple metabolic risk factors.
    Spellman CW
    J Am Osteopath Assoc; 2009 May; 109(5 Suppl):S8-S13. PubMed ID: 19451256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria.
    Schütt M; Kern W; Krause U; Busch P; Dapp A; Grziwotz R; Mayer I; Rosenbauer J; Wagner C; Zimmermann A; Kerner W; Holl RW;
    Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):384-8. PubMed ID: 16915542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Continuous Glucose Monitoring System (CGMS) in type 1 diabetic children is the way to reduce hypoglycemic risk.
    Schiaffini R; Ciampalini P; Fierabracci A; Spera S; Borrelli P; Bottazzo GF; Crinò A
    Diabetes Metab Res Rev; 2002; 18(4):324-9. PubMed ID: 12203948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluating the feature of hypoglycemia detected by continuous glucose monitoring system during temporary continuous subcutaneous insulin infusion in type 2 diabetes patients].
    Li M; Zhou J; Bo YQ; Lu W; Jia WP; Xiang KS
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(24):1679-82. PubMed ID: 19024537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of various methods of intensive insulin therapy in hospital condition assessed by hypoglycaemic episodes detected with the use of continuous glucose monitoring system.
    Mozdzan M; Ruxer J; Loba J; Siejka A; Markuszewski L
    Adv Med Sci; 2006; 51():133-6. PubMed ID: 17357293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal timing for postprandial glucose measurement in pregnant women with diabetes and a non-diabetic pregnant population evaluated by the Continuous Glucose Monitoring System (CGMS).
    Bühling KJ; Winkel T; Wolf C; Kurzidim B; Mahmoudi M; Wohlfarth K; Wäscher C; Schink T; Dudenhausen JW
    J Perinat Med; 2005; 33(2):125-31. PubMed ID: 15843262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous glucose monitoring in diabetic long distance runners.
    Cauza E; Hanusch-Enserer U; Strasser B; Ludvik B; Kostner K; Dunky A; Haber P
    Int J Sports Med; 2005 Nov; 26(9):774-80. PubMed ID: 16237624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of continuous glucose monitoring system (CGMS) to detect postprandial hyperglycemia and unrecognized hypoglycemia in type 1 diabetic patients.
    Maia FF; Araújo LR
    Diabetes Res Clin Pract; 2007 Jan; 75(1):30-4. PubMed ID: 16806560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential lipid profile and hormonal response in type 2 diabetes by exogenous insulin aspart versus the insulin secretagogue repaglinide, at the same glycemic control.
    Chisalita SI; Lindström T; Eson Jennersjö P; Paulsson JF; Westermark GT; Olsson AG; Arnqvist HJ
    Acta Diabetol; 2009 Mar; 46(1):35-42. PubMed ID: 18777156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Usefulness of continuous glucose monitoring system (CGMS) in monitoring glycaemic profile in small children with diabetes type 1].
    Głowińska-Olszewska B; Urban M; Peczyńska J; Florys B; Kowalewski M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(4):237-43. PubMed ID: 16232362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristics of the daily blood glucose profiles of impaired glucose tolerance and type 2 diabetes mellitus subjects by continuous glucose monitoring system].
    Wang XL; Lu JM; Pan CY; Mu YM; Dou JT; Ba JM
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(10):674-7. PubMed ID: 16681924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes.
    Marbury TC; Schwartz S; Rosenberg MA; Jariwala N; Becker RH; Johnston PS
    Exp Clin Endocrinol Diabetes; 2008 May; 116(5):282-8. PubMed ID: 18484560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of improved post-prandial blood glucose control on post-prandial metabolism and markers of vascular risk in people with Type 2 diabetes.
    Gallagher A; Home PD
    Diabetes Res Clin Pract; 2005 Mar; 67(3):196-203. PubMed ID: 15713351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assisting effects of lithium on hypoglycemic treatment in patients with diabetes.
    Hu M; Wu H; Chao C
    Biol Trace Elem Res; 1997; 60(1-2):131-7. PubMed ID: 9404682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-monitoring of blood glucose in people with type 1 and type 2 diabetes living in France: the Entred study 2001.
    Lecomte P; Romon I; Fosse S; Simon D; Fagot-Campagna A
    Diabetes Metab; 2008 Jun; 34(3):219-26. PubMed ID: 18343703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of glycaemic control in patients with Type 2 diabetes on basal insulin and fixed combination oral antidiabetic treatment: results of a pilot study.
    De Mattia G; Laurenti O; Moretti A
    Acta Diabetol; 2009 Mar; 46(1):67-73. PubMed ID: 19030772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Foods with a low glycemic index do not improve glycemic control of both type 1 and type 2 diabetic patients after one month of therapy.
    Calle-Pascual AL; Gomez V; Leon E; Bordiu E
    Diabete Metab; 1988; 14(5):629-33. PubMed ID: 3234586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.